Concordance between mutations in the primary papillary thyroid carcinoma (PTC) and the
paired x lymph node metastasis may elucidate the potential role of molecular targeted …

The BRAF mutation occurs commonly in papillary thyroid carcinoma (PTC). Previous
investigations of its utility to predict recurrence‐free survival (RFS) and disease‐specific …

Purpose We investigated correlations of somatic BRAF V600E mutation and RET/PTC1
rearrangement with recurrent disease in Chinese patients with papillary thyroid carcinoma …

Context: Use of BRAF mutation in papillary thyroid cancer (PTC) has the potential to improve
risk stratification of this cancer. Objective: The objective of the study was to investigate the …

Objective To correlate the presence of BRAF V600E mutation with clinicopathological
parameters. Study Design Case-control study. Setting BRAF mutation represents the most …

Objective BRAF mutation is the commonest mutation seen in papillary thyroid cancer (PTC),
but its prevalence and clinical significance vary across countries. We aim to evaluate the …

Context: Because very few studies have examined the correlation between BRAF mutations
and clinicopathological features of papillary thyroid carcinoma (PTC), we analyzed here a …

BACKGROUND: The incidence of thyroid cancer has doubled over the past decade. The
reason for this dramatic increase in incidence is controversial. Some investigators have …

Background Activating somatic mutation of the BRAF V600E has been identified as the most
common genetic event in papillary thyroid carcinoma (PTC) with a variable frequency (32 …

Purpose To investigate the prognostic value of BRAF V600E mutation for the recurrence of
papillary thyroid cancer (PTC). Patients and Methods This was a retrospective multicenter …